Sola Diagnostics
- Diagnostics
The WID®-easy test revolutionises uterine cancer diagnosis by reducing unnecessary surgical procedures by over 90%(!!!).
We are dedicated to sparing six million women annually from unnecessary diagnostic surgery (hysteroscopy & curettage)—and saving €6 billion in healthcare costs.
The WID®-easy test is already on the market in Austria, Switzerland, and the UK.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}